Clinical Trials Directory

Trials / Completed

CompletedNCT02855840

Auto-immune Diseases and Quality of Life

Qualitative Study of the Consequences of Auto-immune Diseases on Quality of Life

Status
Completed
Phase
Study type
Observational
Enrollment
77 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Systemic lupus erythematous (SLE), systemic sclerosis (Ssc) and inflammatory myopathy (IM) are rare diseases, whose prevalence is estimated at 43, 15 and 10 cases, respectively, for 100 000 inhabitants in France. These diseases belong to the group of auto-immune diseases and require specialized follow-up in an expert centre. The repercussions of SLE, Ssc and IM on the everyday life of patients are heavy, and notably linked to skin involvement, to diminished functional capacities and psychological problems. The vast majority of these diseases concern middle-aged, professionally-active individuals, for whom the socio-professional repercussions are major and too often neglected. The aim of this study is to analyse the consequences of auto-immune diseases on quality of life. Current quality of life questionnaires are not suitable, and do not reveal the reality of the situation and its different nuances. In this research, the quality of life of patients will be envisaged through their everyday lives. How do these patients construct the social reality of the disease? How do they perceive their health status and their social situation? How do they organize their everyday lives around the disease: work, leisure, relationships with their entourage... ?

Conditions

Interventions

TypeNameDescription
OTHERcompletion of the quality of life questionnaire

Timeline

Start date
2015-03-02
Primary completion
2016-03-01
Completion
2017-03-01
First posted
2016-08-04
Last updated
2017-10-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02855840. Inclusion in this directory is not an endorsement.

Auto-immune Diseases and Quality of Life (NCT02855840) · Clinical Trials Directory